News
-
-
-
-
-
-
PRESS RELEASE
Members of the Board and management, and one larger warrant holder, exercise warrants corresponding to SEK 2.3 million
Eurobattery Minerals AB announces exercise of 5,635,169 warrants by Chairman, CEO, and CFO for shares subscription. Total value around SEK 2.3 million. Warrants trading ends on May 17, 2024 -
-
PRESS RELEASE
Eurobattery Minerals publishes Annual Report 2023
Eurobattery Minerals AB publishes its 2023 annual report with an auditor's report indicating significant uncertainty in the company's going concern assumption. Strategic and operational highlights, and detailed financial information are provided -
-
PRESS RELEASE
Eurobattery Minerals signs MoU for carbon-zero mining at the Hautalampi battery mineral project
Eurobattery Minerals AB signs MoU with Okun Energia Oy for local photovoltaic production supporting carbon-zero production of critical raw materials. Partnership aims for carbon-zero production & supports green transition
-
2-10 Home Buyers Warranty and Pearson Smith Realty Team Up to Provide Trusted Protection to Home Sellers
-
Nexus Cognitive Welcomes John Hoffman as New Chief Revenue Officer
-
Eftsure Releases New Cybercrime Risk Mitigation Guide
-
Xcyte Digital Corp. Announces Execution of Definitive Agreement with MCON Live Inc.
-
Gold House Launches First-Ever Gold List for Top Asian Achievements in Television Ahead of Awards Voting Period
-
Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation
-
Form 8.3 - The Vanguard Group, Inc.: International Paper Company
-
Form 8.3 - The Vanguard Group, Inc.: Tyman plc
-
Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc
-
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc
-
Moody’s reaffirms « A1 » Outlook Stable rating of CNP Assurances SA
-
EURAZEO OPENS AN OFFICE IN TOKYO, FURTHER EXTENDING ITS INTERNATIONAL REACH
-
imerys-12-06-2024-implementation-of-the-share-buyback-program
-
COGELEC : Statement on the total number of shares and voting rights.
-
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens